City

Aurora (1)

New Brunswick (1)

Shanghai (1)

Tucson (1)

Condition

Microsatellite Stable Metastatic Colorectal Cancer (2)

Overall Status

Recruiting (2)

Sign in for free

Phase

phase 2 (2)

Sponsor

Criterium, Inc. (1)

Fudan University (1)

Collaborator

ALX Oncology Inc. (1)

Eli Lilly and Company (1)

Merck Sharp & Dohme LLC (1)

Intervention

alx148 (1)

cetuximab (1)

high/low-dose radiotherapy (1)

pembrolizumab (1)

regorafenib (1)

toripalimab (1)

Study Documents

Intervention Type

drug (2)

radiation (1)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

microsatellite stable metastatic colorectal cancer

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Microsatellite Stable Metastatic Colorectal Cancer Trial in Shanghai (Regorafenib, Toripalimab, High/low-dose radiotherapy)

Recruiting

Microsatellite Stable Metastatic Colorectal Cancer

Regorafenib
+2 more

Shanghai, China

Fudan University Shanghai Cancer Center

Jul 19, 2023

Microsatellite Stable Metastatic Colorectal Cancer Trial in Tucson, Aurora, New Brunswick (ALX148, Cetuximab, Pembrolizumab)

Recruiting

Microsatellite Stable Metastatic Colorectal Cancer

ALX148
+2 more

Tucson, Arizona
+2 more

Jul 28, 2022